查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571545

北美外用皮肤治疗市场规模、份额和趋势分析报告：按治疗领域、分销管道、地区和细分市场预测，2024-2030年

North America Topical Skin Treatment Market Size, Share & Trends Analysis Report By Therapeutic Area (Skin Cancer, Eczema, Psoriasis), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 121 Pages | 商品交期: 2-10个工作天内

价格

北美局部皮肤治疗市场成长与趋势：

根据Grand View Research, Inc的最新报告，预计2030年北美局部皮肤治疗市场规模将达到124.5亿美元，2024年至2030年复合年增长率为9.60%。

在几个关键因素的推动下，北美局部皮肤治疗市场正在稳步成长。痤疮、干癣和皮肤炎等皮肤病的增加增加了对有效治疗的需求。消费者对护肤的意识越来越强，对非处方 (OTC) 解决方案的明显偏好，进一步增加了需求。此外，随着人口老化，人们对解决皱纹和老年斑等皮肤老化问题的产品越来越感兴趣。

生物技术的进步，特别是奈米技术和药物输送系统等领域的进步，正在为更有效和更有针对性的治疗铺平道路。在基因组学和人工智慧突破的推动下，个人化皮肤护肤的趋势也是一个充满希望的成长途径。

北美针对非黑色素瘤皮肤癌 (NMSC) 的局部治疗市场预计将取得重大进展，特别是在局部贴片等创新药物传递系统方面。这些进展旨在解决传统局部疗法的局限性，例如药物渗透性差、局部副作用以及患者用药依从性的挑战。

消费者对护肤的认识不断提高以及先进痤疮治疗方法的可用性是预计推动需求的关键因素之一。亚马逊和沃尔玛等电子商务平台的兴起使这些治疗方法更容易获得，并促进了零售商店和线上药局的成长。此外，这些平台提供的便利性和多样性正在鼓励更多消费者寻找和购买痤疮治疗药物。

痤疮治疗方案的持续创新是关键的成长动力。 Sun Pharma 和 Galderma 等公司分别推出了 Winlevi 和 TWYNEO Cream 等新产品，为痤疮治疗提供新颖有效的解决方案。这些产品副作用更少，效果更好，满足消费者不断变化的需求，并且正在推动成长。

策略併购和产品发布在产业扩张中发挥重要作用。例如，2022 年 1 月，Journey Medical Corporation 收购了 FDA核准的局部米诺四环素产品，扩大了产品系列和地理覆盖范围。此外，2021年8月，Sun Pharma 和 Cassiopea 合作在美国和加拿大分销 Winlevi，标誌着两家公司扩大商业性影响力的策略倡议。

北美局部皮肤治疗市场报告亮点

  • 按治疗领域来看，湿疹领域预计将在 2023 年占据市场主导地位，并在预测期内显着成长。这种增长是由于湿疹盛行率的上升、意识的提高以及儿童和老年人口的增加。
  • 从分销通路来看，2023年零售药局领域占据市场主导地位。这一优势得益于广泛的获取和消费者的信任、无需处方笺即可获得产品的便利性以及药剂师的个人指导。
  • 美国凭藉其强大的医疗基础设施、高昂的医疗成本和成熟的製药工业，在北美外用皮肤产品市场占据主导地位。此外，先进治疗方案的可用性，加上製药公司的大力促销努力，确保了消费者的高认知度和可及性。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章：北美局部皮肤治疗市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
    • 市场机会分析
  • 北美局部皮肤治疗市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 价格分析

第四章 北美皮肤外用治疗市场：治疗领域预估及趋势分析

  • 北美局部皮肤治疗市场：治疗领域仪表板
  • 北美局部皮肤治疗市场：治疗领域变化分析
  • 北美局部皮肤治疗市场：按治疗领域分類的收益
  • 皮肤癌
  • 湿疹
  • 干癣
  • 其他治疗领域

第五章北美外用皮肤护理市场：通路估算与趋势分析

  • 北美局部皮肤治疗市场：分销通路仪表板
  • 北美外用皮肤治疗市场：通路波动分析
  • 北美局部皮肤治疗市场：按通路分類的收益
  • 医院药房
  • 零售药房
  • 其他的

第六章北美局部皮肤治疗市场：按治疗区域和分销管道分類的区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • Key company market share analysis, 2023
    • Johnson &Johnson Services, Inc.
    • GSK Plc
    • Pfizer, Inc.
    • Novartis AG
    • LEO Pharma A/S
    • AbbVie, Inc.
    • Bausch Health Companies, Inc.
    • Galderma
    • Sun Pharmaceutical Industries Ltd.
Product Code: GVR-4-68040-450-2

North America Topical Skin Treatment Market Growth & Trends:

The North America topical skin treatment market size is anticipated to reach USD 12.45 billion by 2030, growing at a CAGR of 9.60% from 2024 to 2030, according to a new report by Grand View Research, Inc. The topical skin treatment market in North America is seeing steady growth, fueled by several key factors. Rising rates of skin conditions like acne, eczema, psoriasis, and dermatitis have created a growing need for effective treatments. Consumers are becoming more aware of skincare and showing a clear preference for over-the-counter (OTC) solutions, further boosting demand. Additionally, as the population ages, there is increasing interest in products that address skin aging concerns, such as wrinkles and age spots.

Advancements in biotechnology, especially in areas like nanotechnology and drug delivery systems, are paving the way for more effective and targeted treatments. The trend toward personalized skincare, driven by breakthroughs in genomics and artificial intelligence, is also a promising avenue for growth.

The market for topical treatments targeting Nonmelanoma Skin Cancer (NMSC) in North America is expected to witness significant advancements, particularly in innovative drug delivery systems like topical patches. These advancements aim to address the limitations of conventional topical therapies, such as poor drug penetration, local adverse effects, and patient adherence challenges.

Increasing consumer awareness about skincare and the availability of advanced acne treatments is one of the major factors expected to drive demand. The rise of e-commerce platforms, such as Amazon and Walmart, has made these treatments more accessible, contributing to the growth of retail and online pharmacies. Moreover, the convenience and variety offered by these platforms have encouraged more consumers to seek out and purchase acne treatments.

Continuous innovations in acne treatment options are crucial growth drivers. Companies like Sun Pharma and Galderma have introduced new products, such as Winlevi and TWYNEO Cream, respectively, which offer novel & effective solutions for acne treatment. These products provide better outcomes with fewer adverse effects, meeting the evolving needs of consumers and driving growth.

Strategic mergers & acquisitions, along with product launches, play a significant role in industry expansion. For instance, in January 2022, Journey Medical Corporation acquired FDA-approved topical minocycline products, expanding its product portfolio and geographical reach. In addition, in August 2021, Sun Pharma and Cassiopea partnered for the distribution of Winlevi in the U.S. and Canada, highlighting the strategic moves companies are making to enhance their commercial presence.

North America Topical Skin Treatment Market Report Highlights:

  • Based on therapeutic area, the Eczema segment dominated the market in 2023 and is anticipated to grow significantly over the forecast period. This growth is attributed due to the rising prevalence of eczema, increasing awareness, and growing pediatric and geriatric populations.
  • Based on distribution channel, the retail pharmacies segment dominated the market in 2023. This dominance is attributed due to their widespread accessibility and consumer trust, convenience of obtaining products without a prescription, and personalized guidance from pharmacists.
  • U.S. dominated the North America market for topical skin treatment owing to its robust healthcare infrastructure, high healthcare expenditure, and a well-established pharmaceutical industry. Furthermore, the availability of advanced treatment options, coupled with strong promotional efforts from pharmaceutical companies, ensures high consumer awareness and access.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Therapeutic Areas
    • 1.2.2. Distribution Channel
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Therapeutic Areas outlook
    • 2.2.2. Distribution Channel outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. North America Topical Skin Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. High prevalence of skin diseases
      • 3.2.1.2. Increasing adoption of topical treatments
      • 3.2.1.3. Growing demand for faster and more effective results
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Skin irritation and allergies caused by topical drugs
      • 3.2.2.2. Preference for alternative modes of drug delivery
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Emerging biologic topical treatments for psoriasis
      • 3.2.3.2. Innovative topical therapies for nonmelanoma skin cancer
      • 3.2.3.3. Growth potential in advanced acne treatment solutions
  • 3.3. North America Topical Skin Treatment Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pricing Analysis

Chapter 4. North America Topical Skin Treatment Market: Therapeutic Areas Estimates & Trend Analysis

  • 4.1. North America Topical Skin Treatment Market: Therapeutic Areas Dashboard
  • 4.2. North America Topical Skin Treatment Market: Therapeutic Areas Movement Analysis
  • 4.3. North America Topical Skin Treatment Market: By Therapeutic Areas, Revenue (USD million)
  • 4.4. Skin Cancer
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Fluorouracil (5-FU)
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Imiquimod
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Ingenol Mebutate
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Diclofenac Sodium Gel
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Tirbanibulin Ointment
      • 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.7. Others
      • 4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Eczema
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Corticosteroids
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Calcineurin Inhibitors
      • 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Crisaborole (Eucrisa)
      • 4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.5. Topical Antimicrobials
      • 4.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.6. Emollients and Moisturizers
      • 4.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.7. Others
      • 4.5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Psoriasis
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Corticosteroids
      • 4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Vitamin D Analogues
      • 4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4. Coal Tar
      • 4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.5. Tazarotene
      • 4.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.6. Topical Calcineurin Inhibitors
      • 4.6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.7. Combination Therapies
      • 4.6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.8. Others
      • 4.6.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Other therapeutic areas
    • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. North America topical skin treatment market: Distribution Channel Estimates & Trend Analysis

  • 5.1. North America topical skin treatment market: Distribution Channel Dashboard
  • 5.2. North America topical skin treatment market: Distribution Channel Movement Analysis
  • 5.3. North America topical skin treatment market Estimates and Forecasts, by Distribution Channel, Revenue (USD Million)
  • 5.4. Hospital Pharmacies
    • 5.4.1. Hospital pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Retail Pharmacies
    • 5.5.1. Retail pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Online pharmacies market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. North America topical skin treatment market: Regional Estimates & Trend Analysis By Therapeutic Areas, and Distribution Channel

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company market share analysis, 2023
    • 7.3.2. Johnson & Johnson Services, Inc.
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Product benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. GSK Plc
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Pfizer, Inc.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Novartis AG
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. LEO Pharma A/S
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. AbbVie, Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Bausch Health Companies, Inc.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Galderma
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Sun Pharmaceutical Industries Ltd.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America topical skin treatment market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America topical skin treatment market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 4 North America topical skin treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 5 U.S. North America topical skin treatment market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 6 U.S. topical skin treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 7 Canada topical skin treatment market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 8 Canada topical skin treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 Mexico topical skin treatment market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 10 Mexico topical skin treatment market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 North America Topical Skin Treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic areas and distribution channel snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Pharmaceutical market value, 2023 (USD billion)
  • Fig. 12 Market trends & outlook
  • Fig. 13 Melanoma cases in 2021
  • Fig. 14 Porter's five force analysis
  • Fig. 15 PESTEL analysis
  • Fig. 16 North America topical skin treatment market: Therapeutic areas outlook and key takeaways
  • Fig. 17 North America topical skin treatment market: Therapeutic areas movement analysis
  • Fig. 18 Skin cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Skin cancer cases in 2022
  • Fig. 20 Fluorouracil (5-FU) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Imiquimod market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Ingenol mebutate market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Diclofenac sodium gel market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Tirbanibulin ointment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Eczema market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Prevalence of Atopic Dermatitis (AD) in 2023
  • Fig. 28 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Calcineurin inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Crisaborole (Eucrisa) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Topical antimicrobials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Emollients and moisturizers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Psoriasis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Psoriasis cases (Million)
  • Fig. 36 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Vitamin D analogs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Coal tar market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Tazarotene market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Topical calcineurin inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Combination therapies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 North America topical skin treatment market: Distribution channel outlook and key takeaways
  • Fig. 45 North America topical skin treatment market: Distribution channel movement analysis
  • Fig. 46 Skin cancer, hospital pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Skin cancer, retail pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Skin cancer, other, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Eczema, hospital pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Eczema, retail pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Eczema, other, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Psoriasis, hospital pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Psoriasis, retail pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Psoriasis, other, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Other, hospital pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Other, retail pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 North America topical skin treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 U.S. North America Topical Skin Treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Canada topical skin treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Mexico topical skin treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Market participant categorization
  • Fig. 66 Company market share analysis, 2023
  • Fig. 67 Strategic framework